glp 1 weight loss clinical trials How Did Diabetes Medications Become Meds? Beyond Journal Club on SURMOUNT-1 Trial – Core IM Podcast Who is a Good Candidate

Laser treatment of hyperpigmented lesions: position statement of the European Society of Laser in Dermatology

Nutrients 15(24):5063 Scarpellini C et al (2023) The potential role of regulated cell death in dry eye diseases and ocular surface dysfunction

Eli Lilly and Company has announced positive topline results for the first oral small molecule glucagon-like peptide-1 (GLP-1) receptor agonist, taken without food and water restrictions, to successfully complete a Phase III trial

Puede mejorar la funcin cardaca y la tolerancia al ejercicio en pacientes con enfermedades cardacas especficas, como insuficiencia cardaca congestiva